Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. andchanged its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.

Biotechnology

Clinical Trials

Health Diagnostics

Therapeutics

Visterra Inc.

Brian J.G. Pereira

Mary King Newton-Gruswitz

David Oldach

Zachary Shriver

William C. Tubbs

Jill Yarbrough

Marcia Heron

Jonathan Lonczak

Chris Kiefer

Todd Curtis

Jean Bender

The Leadership Team at Visterra Inc. is responsible for setting the strategic direction of the company, overseeing the development and execution of its pharmaceutical research and development programs, and ensuring operational excellence. This team includes senior executives who manage various critical functions such as scientific research, clinical operations, nonclinical development, regulatory affairs, and financial management, all aimed at advancing therapeutic and diagnostic solutions for infectious diseases.

Leadership Team

Research and Development

Leadership Team

About

Team members

Other teams at Visterra Inc.

Research and Development

Research and Development